Sameer S. Kadri, MD, MS, FIDSA

Intensivist and Head, Clinical Epidemiology Section, Critical Care Medicine Department
National Institutes of Health Clinical Center

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-1694) Estimating the Use of Newer Beta-lactam Gram-negative Targeted Antibiotics Across Greater than 700 Hospitals in the United States
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT